Pharma IQ Members

Behavioural Health

Behavioural Health, as a general concept, refers to the reciprocal relationship between human behavior, individually or socially, and the well-being of the body, mind, and spirit, whether the latter are considered individually or as an integrated whole. Behavioural Health is more commonly used to describe a field of scientific study, academic proficiency and clinical healthcare practice.

Carina Healy & Alan Nelson

You don’t have to be an avid reader of the British Medical Journal to know that healthcare providers in the UK and throughout Europe are under increasing financial strain. A potent combination of changing demographics, rising chronic disease and...

Contributor: Carina Healy & Alan Nelson
09/02/2014 08:00:00 PM EDT
10 Stats from the World Health Statistics Report 2013

The World Health Organisation’s Health Statistics report holds an almost mythical position in the public health community as the fountain of knowledge. It collects vast amounts of data on a huge selection of issues which effect health worldwide....

Contributor: Pharma IQ
05/30/2013 08:00:00 PM EDT
Shirley Williams

Under the umbrella of socializing health care, I recently had the opportunity to interview Colleen Young, Founder of Healthcare Social Media Canada and Engagement & Community Manager of the Canadian Virtual Hospice. The topic was: “ What is...

Contributor: Shirley Williams
12/02/2012 07:00:00 PM EST
Pharma IQ News
Average British health care employee works the equivalent of a seven and a half day weekOne in three say they are doing the work of at least two full-time people10% unable to take holiday this summer because of work pressure15% of workers admit...
Contributor: Pharma IQ News
08/23/2012 08:00:00 PM EDT
Stuart Carroll & Alasdair Williams

As the old aphorism goes, a New Year means a new beginning.  It also provides an opportunity for all of us to make New Year resolutions – promises we make to one or more lasting personal goals, projects, or the reforming of a habit.  In the world...

Contributor: Stuart Carroll & Alasdair Williams
02/07/2012 07:00:00 PM EST
Tania Rodrigues, an analyst at IHS Global Insight

Access to expensive medicines is becoming increasingly difficult in Portuguese public hospitals, while savings with retail pharmacy expenditure are expected to be better than projections in the Memorandum of Understanding deal signed by the...

Contributor: Tania Rodrigues, an analyst at IHS Global Insight
09/29/2011 08:00:00 PM EDT
Simon Mortimore

Simon Mortimore, Head of Information Services, University College London Hospitals NHS Foundation Trust, joins Pharma IQ to discuss developments and challenges in e-health and informatics.

Pharma IQ: Could you explain a bit about what a...

Contributor: Simon Mortimore
08/18/2011 08:00:00 PM EDT
Healthcare IT: UK a European Leader of Investment

Over the past few years, the UK healthcare IT market has grown exponentially to reach an estimated value of almost $3 billion (£1.83 billion) in 2011, making it the second largest in Europe after Germany. And it seems the UK market is set to...

Contributor: Pharma IQ
08/03/2011 08:00:00 PM EDT
Helen Winsor

"Most organisations looked at security over the last couple of years and personal devices wouldn’t have been allowed if it’s portable and encrypted. So we’ve turned things around there. Obviously corporate equipment is still encrypted but we’ve...

Contributor: Helen Winsor
07/19/2011 08:00:00 PM EDT
Andrea Charles

Claus Duedal Pedersen, Head of Centre for Clinical Innovation Odense University Hospital speaks to Andrea Charles from Pharma IQ, about effectively utilising telemedicine and increasing pan-European patient-provider cooperation through RENEWING...

Contributor: Andrea Charles
07/07/2011 08:00:00 PM EDT
Andrea Charles

Healthcare providers across the EU are looking forward to the day when e-health collaboration is a reality and data can flow freely yet securely across institutional and international boundaries. Healthcare IT personnel are working toward this...

Contributor: Andrea Charles
07/06/2011 08:00:00 PM EDT
Pharma IQ News

Pharma IQ is pioneering new HTA discussion platform with launch of the first ever HTA Online event - Global HTA and CER Forum, which will take an innovative form of 12 online session over the course of August.

Health Technology Assessment...

Contributor: Pharma IQ News
06/21/2011 08:00:00 PM EDT
Farouk Saeed

With over 4000 chemicals in a single puff of a cigarette (60 of which are carcinogens)[i], it should come as no surprise why smoking is the single leading cause of preventable illness and premature deaths in the UK. Around 90,000 people are...

Contributor: Farouk Saeed
05/12/2011 08:00:00 PM EDT
Pharma IQ

South Africa's healthcare industry is on the cusp of a revolution. The recently introduced National Health Insurance (NHI) White Paper lays out a plan which would see the country's under-developed healthcare system changed beyond recognition over...

Contributor: Pharma IQ
04/18/2011 08:00:00 PM EDT
Pharma IQ

UK health secretary Andrew Lansley recently announced radical reforms to the country's National Health Service (NHS) aimed at both cutting costs and improving patient care – which some might consider to be two contradictory claims. The Health and...

Contributor: Pharma IQ
01/26/2011 07:00:00 PM EST
Pharma IQ

Chrissie Fletcher, Director and Head of International Biostatistics at Amgen, talks to Helen Winsor from Pharma IQ, about innovation in clinical design, analysis and reporting. Fletcher discusses how she sees health economists and statisticians...

Contributor: Pharma IQ
11/03/2010 08:00:00 PM EDT
Health Technology Assessment Climbs Up the European Agenda due to Lack of Resources

Health Technology Assessment (HTA) is climbing up the agenda in many European countries due to increasing healthcare costs and budgetary pressures.Limited resource According to the European Society of Intensive Care Medicine (ESICM), assessing...

Contributor: Andrea Charles
11/02/2010 08:00:00 PM EDT
Heavy Investment in CER will not Transform the US Healthcare System

The US government's heavy investment in comparative effectiveness research (CER) will not transform the healthcare system, due to the large numbers of uninsured Americans who need to be absorbed into the system.  Integrating the uninsured In a...

Contributor: Andrea Charles
09/16/2010 08:00:00 PM EDT
Pharma IQ

Dr. Franz Hessel, Director of International Health Economics Outcomes Research at Abbott, talks to Andrea Charles from Pharma IQ, about the approaches authorities in leading pharmaceutical markets have taken to the use of Health Technology...

Contributor: Pharma IQ
07/22/2010 08:00:00 PM EDT